Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-28

FDA Approved: NITROFURANTOIN — Original Application (Biocon Pharma Inc)

View source ↗

Summary

The FDA approved Biocon Pharma Inc's original ANDA for nitrofurantoin, a generic antibiotic used to treat urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

ORIG AP for NITROFURANTOIN (NITROFURANTOIN)